$TNXP
Tonix Pharmaceuticals Holding Corp.
XNAS•Health Care•Pharmaceutical Preparations
$9.81
▼-4.20%-$0.430
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateTonix Pharmaceuticals Holding Corp.
XNAS•Health Care•Pharmaceutical Preparations
Why is TNXP down today? It is at $9.81 (-4.20%), and our scanner flagged it 53 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TNXP spikes, and full due diligence on TNXP — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $TNXP 53 times in the last 30 days. Create a free account to track $TNXP, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
TNXP is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on TNXP today, peaking at 2.2x its normal volume.
Likely catalystPharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA®Reported agreement, effective immediately, adds approximately 21 million Medicare lives (38% of approximately 55 million Medicare livesReported and government payer coverage for TONMYA now reaches approximately 166 million covered lives (53% of total U.S. lives)Reported immediately, adding approximately 21 million Medicare lives (38% of approximately 55 million Medicare lives in the U.S.). Medicare, from the latest SEC filing. Read it →Across every filing on file, supply equal to 9% of the tradeable float is in play - 9% more can still be issued.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
615,025 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · Priced at $16.26/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Lederman Seth Officer | Bought (open market) | +2K 0.01% of company | added 22% | 11K | $28K at $13.79 | Aug 27, 26 |
Bagger Richard H Director | Bought (open market) | +1K | n/a | 1K | $13K at $12.60 | Aug 20, 26 |
Saenger Bradley Officer | Acquired (grant/award) | +1K | added 100% | 2K | $16K at $10.91 | Jun 30, 26 |
Taylor Carolyn E. Director | Bought (open market) | +1K | added 100% | 2K | $15K at $10.55 | Jun 12, 26 |
Lederman Seth Officer | Bought (open market) | +5K 0.03% of company | added 100% | 9K | $59K at $11.79 | Jun 9, 26 |
Stillwell Richard Newcomb Director | Bought (open market) | +5K 0.03% of company | n/a | 5K | $58K at $11.65 | Jun 8, 26 |
Lederman Seth Officer | Bought (open market) | +5K 0.03% of company | added 33% | 20K | $63K at $12.62 | Mar 31, 26 |
Lederman Seth Officer | Bought (open market) | +15K 0.09% of company | added 100% | 15K | $223K at $14.89 | Mar 18, 26 |
Taylor Carolyn E. Director | Bought (open market) | +418 | n/a | 418 | $15K at $36.03 | Aug 21, 25 |
Treco James Director | Bought (open market) | +250 | n/a | 250 | $9K at $36.00 | Aug 20, 25 |
Lederman Seth Officer | Bought (open market) | +4K 0.02% of company | added 100% | 4K | $86K at $21.55 | May 15, 25 |
Morris Jessica Edgar Officer | Sold (automatic/other) | -1 | n/a | n/a | n/a | Feb 5, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
TNXP is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on TNXP today, peaking at 2.2x its normal volume.
TNXP last traded at $9.81, down 4.20% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Tonix Pharmaceuticals Holding Corp. (TNXP) is next expected to report earnings on Monday, November 9, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The TNXP Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TNXP 53 times in the last 30 days.
TNXP (Tonix Pharmaceuticals Holding Corp.) trades on XNAS, with a market cap of about $182M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TNXP for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$TNXP discussion
Sign in to ask a question or join the discussion.